Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q2 FY21 results · Jul–Sep 2020
Caplin Point Laboratories reported revenue from operations of ₹268.12 crore and net profit of ₹62.83 crore for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 268.12 | — | — | — | — |
| Other income | 1.76 | — | — | — | — |
| Total income | 269.88 | — | — | — | — |
| Profit before tax | 79.83 | — | — | — | — |
| Net profit for the period | 62.83 | — | — | — | — |
| Attributable to shareholders of the company | 56.89 | — | — | — | — |
| EPS, basic (₹) | 7.52 | — | — | — | — |
| Net margin (%) | 23.4 | — | — |
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 116.92 | 133.26 | −12.3% | 1.20 | 98x |
| Other income | 3.24 | 4.58 | −29.3% | 0.04 | 80x |
| Total income | 120.16 | 137.84 | −12.8% | 1.24 | 97x |
| Profit before tax | 53.99 | 52.69 | +2.5% | 0.56 | 96x |
| Net profit for the period | 41.26 | 39.79 | +3.7% | 0.42 | 98x |
| EPS, basic (₹) | 5.45 | 5.26 | +3.6% | 5.55 | not comparable |
| Net margin (%) | 35.3 | 29.9 | 35.1 |
Consolidated
- Filed with BSE
- 09 Nov 2020, 14:12 IST
- Board meeting
- 05 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2020, 14:12 IST
- Board meeting
- 05 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE